Hologic To Acquire Reveal Genomics To Expand Breast Cancer Diagnostics Portfolio
· pulse2.com · popularity 19/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at pulse2.com →
Summary
Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing genomic diagnostic tests designed to support personalized cancer treatment decisions. The post Hologic To Acquire Reveal Genomics To Expand Breast Cancer Diagnostics Portfolio appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 9.